Argenx SE
Belgium
1 July 2018 - 30 June 2019
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Argenx SE published between 1 July 2018 - 30 June 2019 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 3 | 1.26 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 3 | 1.26 | |
Top articles by Altmetric score in current window
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
Journal of Clinical Investigation
2018-07-24
1 July 2018 - 30 June 2019
International vs. domestic collaboration by FC
- 49.85% Domestic
- 50.15% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by FC (4 total)
- Argenx SE, Belgium
- Domestic institution
Top 10 international collaborators by FC (8 total)
- Argenx SE, Belgium
- Foreign institution
-
Texas A&M University (TAMU), United States of America (USA)
(1)
-
Ludwig Cancer Research, United States of America (USA)
(0.33)
-
Centre de Recherche en Cardiovasculaire et Nutrition (C2VN), France
(0.28)
-
Aix-Marseille University (AMU), France
(0.25)
-
French National Institute for Agricultural Research (INRA), France
(0.23)
-
National Institute for Health and Medical Research (INSERM), France
(0.23)
-
Karolinska Institute (KI), Sweden
(0.23)
-
Erasmus University Rotterdam (EUR), Netherlands
(0.21)
Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
